Australia markets close in 4 hours 57 minutes

Addex Therapeutics Ltd (ADXN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.51-0.12 (-1.39%)
At close: 11:17AM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 551.49M
Enterprise value 332.38M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)11.02
Price/book (mrq)2.79
Enterprise value/revenue 38.79
Enterprise value/EBITDA 7-2.62

Trading information

Stock price history

Beta (5Y monthly) 1.46
52-week change 3-31.67%
S&P500 52-week change 330.48%
52-week high 335.00
52-week low 38.28
50-day moving average 39.32
200-day moving average 39.82

Share statistics

Avg vol (3-month) 32.38k
Avg vol (10-day) 31.56k
Shares outstanding 55.69M
Implied shares outstanding 6N/A
Float 82.34M
% held by insiders 10.00%
% held by institutions 18.94%
Shares short (29 Sept 2021) 41.16k
Short ratio (29 Sept 2021) 40.58
Short % of float (29 Sept 2021) 4N/A
Short % of shares outstanding (29 Sept 2021) 40.02%
Shares short (prior month 30 Aug 2021) 43.76k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 June 2021


Profit margin 0.00%
Operating margin (ttm)-317.18%

Management effectiveness

Return on assets (ttm)-35.39%
Return on equity (ttm)-72.50%

Income statement

Revenue (ttm)3.99M
Revenue per share (ttm)0.79
Quarterly revenue growth (yoy)15.00%
Gross profit (ttm)-6.47M
EBITDA -12.81M
Net income avi to common (ttm)-12.77M
Diluted EPS (ttm)-2.74
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.15M
Total cash per share (mrq)3.19
Total debt (mrq)420.16k
Total debt/equity (mrq)2.56
Current ratio (mrq)5.70
Book value per share (mrq)2.89

Cash flow statement

Operating cash flow (ttm)-11.07M
Levered free cash flow (ttm)-6.3M